+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmacovigilance & Drug Safety Software Market Research Report by Product, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968703
  • Report
  • July 2021
  • Region: Global
  • 180 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Pharmacovigilance & Drug Safety Software Market will Grow to USD 353.02 Million by 2026, at a CAGR of 8.72%

FEATURED COMPANIES

  • 4C PHARMA SOLUTIONS
  • Accenture
  • Clinevo Technologies
  • Ennov
  • Indegene
  • Oracle Corporation
  • MORE
The Global Pharmacovigilance & Drug Safety Software Market size was estimated at USD 213.72 Million in 2020 and expected to reach USD 231.64 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.72% to reach USD 353.02 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmacovigilance & Drug Safety Software to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Pharmacovigilance & Drug Safety Software Market was studied across Adverse Event Reporting Software, Drug Safety Audits Software, Fully Integrated Software, and Issue Tracking Software.
  • Based on End User, the Pharmacovigilance & Drug Safety Software Market was studied across Business Process Outsourcing Firms, Contract Research Organizations, Pharma & Biotech Companies, and Pharmacovigilance Service Providers.
  • Based on Distribution, the Pharmacovigilance & Drug Safety Software Market was studied across On-Cloud and On-Premise.
  • Based on Region, the Pharmacovigilance & Drug Safety Software Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmacovigilance & Drug Safety Software Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmacovigilance & Drug Safety Software Market, including 4C PHARMA SOLUTIONS, AB Cube, Accenture, Advera Health Analytics, Inc., ArisGlobal, Clinevo Technologies, Cognizant, Ennov, Extedo GMBH, Indegene, IQVIA Inc., Online Business Applications, Oracle Corporation, Sarjen Systems Pvt, Sparta Systems, UMBRA Global LLC, United BioSource Corporation, VigiFlow, and Wipro.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pharmacovigilance & Drug Safety Software Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmacovigilance & Drug Safety Software Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmacovigilance & Drug Safety Software Market?
4. What is the competitive strategic window for opportunities in the Global Pharmacovigilance & Drug Safety Software Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmacovigilance & Drug Safety Software Market?
6. What is the market share of the leading vendors in the Global Pharmacovigilance & Drug Safety Software Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmacovigilance & Drug Safety Software Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 4C PHARMA SOLUTIONS
  • Accenture
  • Clinevo Technologies
  • Ennov
  • Indegene
  • Oracle Corporation
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. End User Outlook
3.5. Distribution Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for pharmacovigilance and drug safety monitoring by product developers, license holders and clinical investigators
5.1.1.2. Need to reduce time spent reviewing medical literature for aggregate reports and safety signals
5.1.1.3. Increasing investment by pharmaceuticals companies
5.1.1.4. Highly regulated pharmacovigilance space
5.1.2. Restraints
5.1.2.1. Expensive deployments
5.1.3. Opportunities
5.1.3.1. Third party dependency for pharmacovigilance and drug safety
5.1.3.2. Use of AI and machine learning models automatically to identify references in scientific literature
5.1.4. Challenges
5.1.4.1. Limited awareness
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Pharmacovigilance & Drug Safety Software Market, by Product
6.1. Introduction
6.2. Adverse Event Reporting Software
6.3. Drug Safety Audits Software
6.4. Fully Integrated Software
6.5. Issue Tracking Software

7. Pharmacovigilance & Drug Safety Software Market, by End User
7.1. Introduction
7.2. Business Process Outsourcing Firms
7.3. Contract Research Organizations
7.4. Pharma & Biotech Companies
7.5. Pharmacovigilance Service Providers

8. Pharmacovigilance & Drug Safety Software Market, by Distribution
8.1. Introduction
8.2. On-Cloud
8.3. On-Premise

9. Americas Pharmacovigilance & Drug Safety Software Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Pharmacovigilance & Drug Safety Software Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 4C PHARMA SOLUTIONS
13.2. AB Cube
13.3. Accenture
13.4. Advera Health Analytics, Inc.
13.5. ArisGlobal
13.6. Clinevo Technologies
13.7. Cognizant
13.8. Ennov
13.9. Extedo GMBH
13.10. Indegene
13.11. IQVIA Inc.
13.12. Online Business Applications
13.13. Oracle Corporation
13.14. Sarjen Systems Pvt
13.15. Sparta Systems
13.16. UMBRA Global LLC
13.17. United BioSource Corporation
13.18. VigiFlow
13.19. Wipro

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 4. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 5. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 6. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 10. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2026
FIGURE 12. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 21. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2026
FIGURE 23. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
FIGURE 32. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2026
FIGURE 34. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: SCORES
TABLE 47. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: BUSINESS STRATEGY
TABLE 48. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: PRODUCT SATISFACTION
TABLE 49. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: RANKING
TABLE 50. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 51. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: MERGER & ACQUISITION
TABLE 52. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 53. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 54. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: INVESTMENT & FUNDING
TABLE 55. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 56. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 4C PHARMA SOLUTIONS
  • AB Cube
  • Accenture
  • Advera Health Analytics, Inc.
  • ArisGlobal
  • Clinevo Technologies
  • Cognizant
  • Ennov
  • Extedo GMBH
  • Indegene
  • IQVIA Inc.
  • Online Business Applications
  • Oracle Corporation
  • Sarjen Systems Pvt
  • Sparta Systems
  • UMBRA Global LLC
  • United BioSource Corporation
  • VigiFlow
  • Wipro
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll